Common Eye Diseases
Here are examples of the impact on vision of three common eye diseases that impact Canadians.
The Workplace Cost of Eye Disease
Millions of Canadians, many of which are in the workforce, are at risk of developing a serious eye disease like diabetic retinopathy, age-related macular degeneration (AMD), or glaucoma. When these conditions go undetected, they can have serious consequences for employees and workplaces alike. Early detection can prevent more than 90% of vision loss in Canada, reducing the impact of eye disease, and avoiding cost for insurers and plan sponsors.
Eye disease can have a major impact on a patient’s quality of life, particularly if not detected and treated at the early stages of disease.
For example:
- Early or mild diabetic retinopathy, AMD and glaucoma have a similar impact on quality of life as moderate angina or a moderate heart attack.
- Moderate stages of eye disease have a similar impact to breast cancer treated with chemotherapy, or kidney disease requiring a transplant.
- Advanced or severe stages of eye disease have a similar impact on quality of life to severe angina, a severe heart attack or a major stroke.
Treatment Pathways For Eye Disease
As estimated 8 million Canadians have an eye disease that can lead to vision loss, including diabetic retinopathy, AMD, and glaucoma. These conditions often remain symptom-free until they reach an advanced stage, making treatment more complex and costly. Preventative care results in an earlier diagnosis, fewer interventions, and lower costs compared to catching a disease at an advanced stage.